成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 38585-74-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 38585-74-9
Chemical Structure| 38585-74-9
Structure of 38585-74-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 38585-74-9 ]

Related Doc. of [ 38585-74-9 ]

Alternatived Products of [ 38585-74-9 ]
Product Citations

Product Details of [ 38585-74-9 ]

CAS No. :38585-74-9 MDL No. :MFCD04115732
Formula : C4H5NOS Boiling Point : -
Linear Structure Formula :- InChI Key :WKBQQWDVVHGWDB-UHFFFAOYSA-N
M.W : 115.15 Pubchem ID :2763216
Synonyms :
Chemical Name :Thiazol-5-ylmethanol

Calculated chemistry of [ 38585-74-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.25
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 28.24
TPSA : 61.36 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.19
Log Po/w (XLOGP3) : 0.1
Log Po/w (WLOGP) : 0.48
Log Po/w (MLOGP) : -0.88
Log Po/w (SILICOS-IT) : 2.01
Consensus Log Po/w : 0.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.08
Solubility : 9.59 mg/ml ; 0.0833 mol/l
Class : Very soluble
Log S (Ali) : -0.94
Solubility : 13.1 mg/ml ; 0.114 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.07
Solubility : 9.85 mg/ml ; 0.0855 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.01

Safety of [ 38585-74-9 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P501-P273-P280-P305+P351+P338+P310 UN#:N/A
Hazard Statements:H318-H412 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38585-74-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38585-74-9 ]

[ 38585-74-9 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 32955-22-9 ]
  • [ 38585-74-9 ]
YieldReaction ConditionsOperation in experiment
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate C.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (2.89 g, 76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 minutes.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent -2percent -4percent methanol in chloroform, to provide the desired compound, Rf-0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3) δ4.92 (s, 2H), 7.78 (s, 1H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate P.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the flitrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent -2percent-4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3)δ4.92
(s, 2H), 7.78 (s, 1H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate K.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent - 2percent - 4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3) δ4.92 (s, 2H), 7.78 (s, 1 H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate K.
5-(Hydroxymethyl)thiazole.
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent-2percent-4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3) δ4.92
(s, 2H), 7.78 (s, 1H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate D.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol)in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two flitrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent-2percent-4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield.
NMR (CDCl3) δ4.92 (s, 2 H), 7.78 (s, 1 H), 8.77 (s, 1 H).
Mass spectrum: (M+H)+ =116.

Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 7, p. 3124 - 3153
[2] Journal of Medicinal Chemistry, 1998, vol. 41, # 4, p. 602 - 617
[3] Patent: US5914332, 1999, A,
[4] Patent: US5455351, 1995, A,
[5] Patent: US5559158, 1996, A,
[6] Patent: US5484801, 1996, A,
[7] Patent: US5461067, 1995, A,
[8] Patent: EP1170289, 2002, A2, . Location in patent: Page 44-45
[9] Helvetica Chimica Acta, 1952, vol. 35, p. 215
[10] Journal of Medicinal Chemistry, 1973, vol. 16, p. 978 - 984
[11] Patent: US5559158, 1996, A,
[12] Patent: US5484801, 1996, A,
  • 2
  • [ 14527-44-7 ]
  • [ 38585-74-9 ]
YieldReaction ConditionsOperation in experiment
69%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran; diethyl ether at 0℃; for 1 h;
Stage #2: With sodium hydroxide In water at 0℃; for 0.5 h;
A mixture of 0. 54 g of g-4 and 10ml tetrahydrofurane (THF) was stirred at 0°C under a nitrogen atmosphere. The mixture of 0. 16g of lithium aluminium hydride and 5ml of ether was added drop wise. After lhour at 0°C water and 20percent sodium hydroxide were added, and stirred during 30 minutes. The mixture was filtered over decalite and the solvent was removed by azeotropique distillation with toluene yielding 0.3g (69percent) of thiazol-5-yl-methanol (g-5).
Reference: [1] Patent: WO2003/97616, 2003, A1, . Location in patent: Page/Page column 26
[2] Patent: US5968942, 1999, A,
[3] Patent: US6046190, 2000, A,
  • 3
  • [ 170232-68-5 ]
  • [ 38585-74-9 ]
Reference: [1] Synthetic Communications, 1995, vol. 25, # 17, p. 2639 - 2645
[2] Synthetic Communications, 1995, vol. 25, # 24, p. 4081 - 4086
[3] Journal of Labelled Compounds and Radiopharmaceuticals, 2009, vol. 52, # 4, p. 110 - 113
  • 4
  • [ 1003-32-3 ]
  • [ 38585-74-9 ]
Reference: [1] Journal of Materials Chemistry, 2009, vol. 19, # 19, p. 2975 - 2985
[2] Journal of medicinal chemistry, 1998, vol. 41, # 26, p. 5265 - 5271
[3] Patent: US5780638, 1998, A,
[4] Patent: US2009/170907, 2009, A1, . Location in patent: Page/Page column 59
[5] Patent: WO2010/132999, 2010, A1, . Location in patent: Page/Page column 112
  • 5
  • [ 145015-15-2 ]
  • [ 38585-74-9 ]
Reference: [1] Patent: US5959118, 1999, A,
[2] Patent: US5773625, 1998, A,
  • 6
  • [ 170232-69-6 ]
  • [ 38585-74-9 ]
Reference: [1] Synthetic Communications, 1995, vol. 25, # 24, p. 4081 - 4086
  • 7
  • [ 262444-15-5 ]
  • [ 38585-74-9 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2009, vol. 52, # 4, p. 110 - 113
  • 8
  • [ 145015-15-2 ]
  • [ 67000-01-5 ]
  • [ 38585-74-9 ]
Reference: [1] Patent: US5712400, 1998, A,
  • 9
  • [ 1167055-75-5 ]
  • [ 75-45-6 ]
  • [ 38585-74-9 ]
Reference: [1] Patent: US5395845, 1995, A,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 38585-74-9 ]

Ritonavir Related Intermediates

Chemical Structure| 154212-60-9

[ 154212-60-9 ]

2-Isopropyl-4-(methylaminomethyl)thiazole

Chemical Structure| 59830-60-3

[ 59830-60-3 ]

(S)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate

Chemical Structure| 72155-45-4

[ 72155-45-4 ]

tert-Butyl (S)-(1-oxo-3-phenylpropan-2-yl)carbamate

Chemical Structure| 32955-22-9

[ 32955-22-9 ]

Ethyl 5-thiazolecarboxylate

Chemical Structure| 144163-97-3

[ 144163-97-3 ]

4-Nitrophenyl (thiazol-5-ylmethyl) carbonate

Related Functional Groups of
[ 38585-74-9 ]

Alcohols

Chemical Structure| 131184-73-1

[ 131184-73-1 ]

(2-Aminothiazol-5-yl)methanol

Similarity: 0.82

Chemical Structure| 687636-93-7

[ 687636-93-7 ]

2-Bromothiazole-5-methanol

Similarity: 0.78

Chemical Structure| 202932-04-5

[ 202932-04-5 ]

5-Methyl-2-thiazolemethanol

Similarity: 0.76

Chemical Structure| 262444-15-5

[ 262444-15-5 ]

(4-Bromothiazol-5-yl)methanol

Similarity: 0.74

Chemical Structure| 131748-97-5

[ 131748-97-5 ]

(2-(Trifluoromethyl)thiazol-5-yl)methanol

Similarity: 0.69

Related Parent Nucleus of
[ 38585-74-9 ]

Thiazoles

Chemical Structure| 131184-73-1

[ 131184-73-1 ]

(2-Aminothiazol-5-yl)methanol

Similarity: 0.82

Chemical Structure| 3581-89-3

[ 3581-89-3 ]

5-Methylthiazole

Similarity: 0.80

Chemical Structure| 687636-93-7

[ 687636-93-7 ]

2-Bromothiazole-5-methanol

Similarity: 0.78

Chemical Structure| 14527-41-4

[ 14527-41-4 ]

5-Thiazolecarboxylic acid

Similarity: 0.78

Chemical Structure| 202932-04-5

[ 202932-04-5 ]

5-Methyl-2-thiazolemethanol

Similarity: 0.76

; ;